- ￥1200 - 1900
- MedChemExpress(MCE)
- 美国
- HY-145412
- 2025年12月05日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
4°C, protect from light
- 库存：
货期：1-2天
- 供应商：
MedChemExpress LLC
- CAS号：
2736447-04-2
- 规格：
5 mg/10 mg
| 规格： | 5 mg | 产品价格： | ￥1200.0 |
|---|---|---|---|
| 规格： | 10 mg | 产品价格： | ￥1900.0 |
MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。
GLP-1 receptor agonist 7
CAS No. : 2736447-04-2
MCE 国际站：GLP-1 receptor agonist 7
产品活性：GLP-1 receptor agonist 7 是胰高血糖素样肽-1 (GLP-1) 的有效激动剂。GLP-1 受体激动剂 7 具有研究 GLP-1 相关疾病、障碍和病症 (包括糖尿病) 的潜力 (信息提取自专利 WO2021219019A1, compound 130b)。
研究领域：GPCR/G Protein
作用靶点：GCGR
相关产品：Exendin-4 | Semaglutide | Liraglutide | Glucagon (1-29), bovine, human, porcine | Exendin(9-39) amide | Retatrutide | GLP-1(7-37) | GLP-1(7-36), amide acetate | Orforglipron | MK 0893 | Adomeglivant | BETP | GLP-1(9-36)amide | GLP-1R Antagonist 1 | Oxyntomodulin (bovine, porcine) | Cotadutide acetate | GLP-2(1-33)(human) | Beinaglutide | LGD-6972 | NNC-0640 | Lixisenatide | PF-06291874 | GLP-2(3-33) | Lotiglipron | GLP-1 moiety from Dulaglutide
热门产品线：重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Elucidating Agonist-Selective Mechanisms of G Protein-Coupled Receptor Desensitization
to agonist-dependent regulation. In the case of the μ-opioid receptor (MOPr), we have shown that two agonists, morphine and the peptide agonist DAMGO, can induce MOPr desensitization by different mechanisms involving largely protein kinase C
PPAR/ Agonist Increases the Expression of PGE2 Receptor Subtype EP4 in Human Lung Carcinoma Cells
an important role in the effort to help extend its dismal 5-year survival rate (2 (PGE2 ), and the prostag-landin E2 receptor subtype, EP4, promote the growth and progression of human nonsmall cell lung carcinoma (NSCLC), the most common lung carcinoma
. These include receptormediated GDP release, GTP binding, and GTP hydrolysis. Fig. 1. Schematic diagram of receptor-mediated activation/mactivation cycle of G protein ( see Introduction for detailed comments). A, agonist; R
技术资料暂无技术资料 索取技术资料
